BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2983958)

  • 1. [Cell fusion and activation of Epstein-Barr virus (EBV)].
    Liu YX
    Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):15-8. PubMed ID: 2983958
    [No Abstract]   [Full Text] [Related]  

  • 2. [Demonstration of Epstein-Barr virus (EBV)-related antigens and tumorigenicity in nude mice in a hybrid cell line derived from the fusion of an EBV-positive lymphoblastoid cell and an EBV-negative epithelial cell from the human nasopharynx].
    Ishiguro H
    Nihon Jibiinkoka Gakkai Kaiho; 1984 Jun; 87(6):693-707. PubMed ID: 6092593
    [No Abstract]   [Full Text] [Related]  

  • 3. Establishment of Epstein-Barr virus (EBV) infection in epithelial cells derived from the nasopharynx by cell fusion.
    Takimoto T; Morishita K; Furukawa M; Umeda R; Hatano M
    J Laryngol Otol; 1983 Aug; 97(8):719-26. PubMed ID: 6310010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the synthesis of Epstein-Barr virus-related antigens induced by superinfection].
    Fujiwara S
    Hokkaido Igaku Zasshi; 1984 Sep; 59(5):586-602. PubMed ID: 6096242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.
    Bhaduri-McIntosh S; Landry ML; Nikiforow S; Rotenberg M; El-Guindy A; Miller G
    J Infect Dis; 2007 Feb; 195(4):483-92. PubMed ID: 17230407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
    Delecluse HJ; Feederle R; Behrends U; Mautner J
    Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of EA-D of Epstein-Barr virus.
    Chen LW; Lin LS; Chang YS; Liu ST
    Virology; 1995 Aug; 211(2):593-7. PubMed ID: 7645263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of LMP1 in immune control of EBV infection.
    Pai S; Khanna R
    Semin Cancer Biol; 2001 Dec; 11(6):455-60. PubMed ID: 11669607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epstein-Barr virus (EBV) infection of epithelial cells from the nasopharynx--the use of autoradiography (author's transl)].
    Takimoto T; Morishita K; Furukawa M; Sugimori S
    Nihon Jibiinkoka Gakkai Kaiho; 1979 Nov; 82(11):1388-93. PubMed ID: 231647
    [No Abstract]   [Full Text] [Related]  

  • 13. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
    Pearson G; Dewey F; Klein G; Henle G; Henle W
    J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection of normal human thymic epithelial cells by Epstein-Barr virus (EBV) following implantation of EBV receptors.
    Seshi B; Volsky B; Anderson RW; Purtilo DT; Volsky DJ
    Thymus; 1984; 6(1-2):5-13. PubMed ID: 6087504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-specific cytoskeletal early antigen in EBV-transformed cell lines.
    Sairenji T; Nguyen QV; Woda B; Humphreys RE
    AIDS Res; 1986 Dec; 2 Suppl 1():S57-60. PubMed ID: 3030348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC
    Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elaboration of optical immunosensors based on the surface plasmon resonance for detecting specific antibodies and antigens of Epstein-Barr virus and human adenovirus.
    Nesterova NV; Nosach LM; Zagorodnya SD; Povnitsa OY; Boltovets PM; Baranova GV; Golovan AV
    Mikrobiol Z; 2008; 70(6):67-73. PubMed ID: 19351051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E; Ernberg I; Masucci MG; Szigeti R; Wu YT; Masucci G; Svedmyr E
    Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attempt to infect nonmalignant nasopharyngeal epithelial cells from humans and squirrel monkeys with Epstein-Barr virus.
    Glaser R; Lang CM; Lee KJ; Schuller DE; Jacobs D; McQuattie C
    J Natl Cancer Inst; 1980 May; 64(5):1085-90. PubMed ID: 6245300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.